Seer, Inc.SEEREarnings & Financial Report
Nasdaq · Health Care · Laboratory Analytical Instruments
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
SEER Q4 FY2025 Key Financial Metrics
Revenue
$4.2M
Gross Profit
$2.2M
Operating Profit
$-17.4M
Net Profit
$-16.0M
Gross Margin
52.0%
Operating Margin
-413.8%
Net Margin
-380.7%
YoY Growth
5.0%
Seer, Inc. Q4 FY2025 Financial Summary
Seer, Inc. reported revenue of $4.2M (up 5.0% YoY) for Q4 FY2025, with a net profit of $-16.0M (up 26.4% YoY) (-380.7% margin). Cost of goods sold was $2.0M, operating expenses totaled $19.6M.
Key Financial Metrics
| Total Revenue | $4.2M |
|---|---|
| Net Profit | $-16.0M |
| Gross Margin | 52.0% |
| Operating Margin | -413.8% |
| Report Period | Q4 FY2025 |
Seer, Inc. Annual Revenue by Year
Seer, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $16.6M).
Seer, Inc. Quarterly Revenue & Net Profit History
Seer, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $4.2M | +5.0% | $-16.0M | -380.7% |
| Q3 FY2025 | $4.1M | +2.2% | $-18.2M | -442.5% |
| Q2 FY2025 | $4.1M | +31.9% | $-19.4M | -479.5% |
| Q1 FY2025 | $4.2M | +37.1% | $-19.9M | -474.4% |
| Q4 FY2024 | $4.0M | -9.9% | $-21.7M | -543.6% |
| Q3 FY2024 | $4.0M | -3.1% | $-21.3M | -529.0% |
| Q2 FY2024 | $3.1M | -23.4% | $-22.9M | -743.8% |
| Q1 FY2024 | $3.1M | -24.4% | $-20.7M | -674.5% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.1M | $3.1M | $4.0M | $4.0M | $4.2M | $4.1M | $4.1M | $4.2M |
| YoY Growth | -24.4% | -23.4% | -3.1% | -9.9% | 37.1% | 31.9% | 2.2% | 5.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $422.0M | $406.6M | $383.4M | $366.6M | $347.3M | $322.5M | $308.6M | $296.1M |
| Liabilities | $38.4M | $41.9M | $38.7M | $39.0M | $36.3M | $34.2M | $36.8M | $36.8M |
| Equity | $383.6M | $364.7M | $344.7M | $327.6M | $311.0M | $288.3M | $271.8M | $259.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-10.5M | $-10.1M | $-14.1M | $-11.5M | $-11.4M | $-14.7M | $-7.6M | $-10.8M |